General information
| Name: Gary |
| Surname: Stack |
| E-mail: gstack@ait.ie |
| Cell phone number with international prefix: 00353906442546 |
| Country: Ireland |
| Affiliation: Athlone Institute of Technology |
| Gender: F □ M x |
| Year of the PhD title: 2013 |
| Personal web page: http://www.researchgate.net/profile/Gary_Stack3 |
| Previous COST participation: No x Yes □ |
List of 10 selected publications within last 5 years
| 1. Stack GD, Walsh JJ. Optimising the delivery of tubulin targeting agents through antibody conjugation. Pharmaceutical Research. 2012; 29(11):2972-84 |
| 2. Walsh JJ, Stack GD. Linker technologies and release mechanisms for antibody-drug conjugates. Optimizing Antibody-Drug Conjugates for Targeted Delivery of Therapeutics. Future Science Book Series: Future Science Ltd; 2015. p. 40-55 |
| 3. |
| 4. |
| 5. |
| 6. |
| 7. |
| 8. |
| 9. |
| 10. |
Main skills and expertise (up to 5)
| 1. Organic Synthesis |
| 2. Flash Chromatography |
| 3. NMR Analysis |
| 4. Cell culture |
| 5. |
Main equipment/facilities available in the participants’ lab (up to 5)
| 1. GC-MS |
| 2. Access to high-field NMR |
| 3. |
| 4. |
| 5. |
Short personal activity proposal for the COST Action CA15135 (max 1000 characters)
| The major focus of my PhD research was on the synthesis of novel multi-target drugs. I am very enthusiastic about expanding upon the work that I have carried out in this area and would very much appreciate the opportunity to collaborate with others working on this topic. I am at early stage in my research career and am actively attempting to pursue independent research. I would welcome any opportunity to discuss collaboration with other members of CA15135. |
Work Group preference: score from 1 (preferred) to 4 (not preferred)
| Work Group of the CA15135 COST Action | Score |
| WG1: Development of new chemical entities | 1 |
| WG2: Selection of biological targets and assessment of biological data | 2 |
| WG3: Development of chemical databases | 3 |
| WG4: Development of Computational methods for multiple ligand design and discovery | 4 |
